5.8 Kawasaki disease
Introduction
Kawasaki disease (KD) is an acute, self-limiting vasculitic illness predominantly affecting infants and young children. It is now a leading cause of acquired heart disease in children in Western countries. The diagnosis is made clinically, and effective treatment is available to reduce the likelihood of potentially fatal coronary vasculitis. KD was first described in 1967 as ‘mucocutaneous lymph node syndrome’ in a series of 50 Japanese children.1 Although it is most common in Japanese and Korean children (annual incidence 90–150/100 000 children younger than five years), it occurs in all ethnic groups, with an annual incidence in the United States of approximately 10/100 000 children younger than 5 years old. The majority of cases (85%) occur in children aged less than 5 years of age. It is 1.5 times more common in boys than girls.2
There is debate as to whether the inflammatory response in KD is initiated by a conventional antigen or a superantigen, and there are some immunological features to support both hypotheses. Unreplicated reports of increased expression of specific T-cell receptor V β-regions suggests toxin activation, whereas infiltration of paratracheal and vascular tissue with reactive clonal IgA plasma cells suggests entry of a conventional antigen via the respiratory route.3
Pathophysiology
The pathophysiology of KD involves vasculitis of medium-sized vessels including coronary, renal, hepatic and splanchnic arteries, beginning in both adventitial and intimal surfaces and proceeding toward the media. Coronary changes occur in approximately 20% of untreated patients.4 Immune activation involving cytokines and growth factors leads to inflammation and aneurysm formation, with the risk of thrombosis. The process evolves for a long period after the acute illness. In the majority of patients with echocardiographically demonstrable coronary artery lesions, the vessels remodel and have a normal appearance within a year or so. However, there is evidence of subtle long-term changes in coronary artery function, the clinical significance of which remain unclear.5 The risk of early adult coronary artery disease in these patients is unknown.
A diffuse inflammatory process of a variety of tissues has been found in autopsy specimens including lymph nodes, liver and gall-bladder.2 Endothelial changes are prominent, with hyperplasia, necrosis and thrombosis. Myocardial abnormalities include hypertrophy of myocytes and fibrosis.
Clinical features
KD should be considered in the differential diagnosis of all infants and young children with a fever, rash and red eyes, as well as those with a prolonged fever without an alternative explanation. The diagnostic criteria are outlined in Table 5.8.1.
The diagnosis can be made earlier than day 5 if other features are present. This is important, as there is evidence that earlier administration of intravenous immunoglobulin (IVIG) is associated with a shorter illness and reduced risk of coronary disease.6
KD is a multisystem disease with many and varied clinical manifestations. In addition to those in the diagnostic criteria, common features include marked irritability, diarrhoea, cough, arthralgia/arthritis, urethritis with sterile pyuria, otitis media, mild hepatic dysfunction, hydrops of the gallbladder and aseptic meningitis. Diagnosis is more likely to be delayed in older children, in whom less classical manifestations such as gastrointestinal and joint symptoms often predominate.7